Skip to content
Dosage GuideResearch Reference

Abarelix Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Abarelix. All information is for educational purposes only.

Quick Answer

Abarelix was administered at 100 mg via intramuscular injection on days 1, 15, and 29, then every 4 weeks thereafter. Due to anaphylaxis risk, administration required a healthcare setting with a 30-minute post-injection observation period. It is no longer widely used, having been superseded by safer GnRH antagonists.

→ Abarelix Benefits→ Abarelix Side Effects→ Full Abarelix Profile
Table of Contents

Standard Dosage Range

Research dosing range: 100 mg

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Advanced Prostate Cancer (initial loading)

100 mgDays 1, 15, 29
Duration

3 doses

Intramuscular injection. Loading doses to rapidly achieve castrate testosterone levels.

Advanced Prostate Cancer (maintenance)

100 mgEvery 4 weeks
Duration

Ongoing

Intramuscular injection. Maintenance dose to sustain testosterone suppression. Requires 30-minute post-injection monitoring.

Patients Unsuitable for GnRH Agonists

100 mgAs above (loading and maintenance)
Duration

Ongoing

Used when testosterone flare from agonists is unacceptable (e.g., spinal cord compression risk).

Timing & Frequency

Administered as scheduled by a healthcare professional in a clinical setting due to the risk of anaphylaxis. Timing is less critical than adherence to the strict administration protocol.

Cycle Guidance

Abarelix treatment was generally continuous for as long as testosterone suppression was clinically indicated. Cycling was not typically employed. Monitor for side effects and allergic reactions.

Reconstitution Reference

Quick reference for reconstituting Abarelix. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial Size100 mg per vial
BAC Water VolumeNot applicable; supplied as a pre-mixed suspension
Concentration & Draw100 mg/mL
StorageStore refrigerated at 2–8°C. Protect from light.
StabilityRefer to manufacturer's instructions. Do not use if particulate matter or discoloration is present.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What was the typical abarelix dosage regimen?
The standard regimen was 100 mg intramuscularly on days 1, 15, and 29 (weeks 1, 2, and 4), followed by 100 mg every 4 weeks thereafter for maintenance.
Why did abarelix require a 30-minute observation period?
A 1.1% risk of immediate-onset systemic allergic reactions, including anaphylaxis, mandated a 30-minute observation period with readily available emergency resuscitation equipment.
How was abarelix administered?
Abarelix was administered via intramuscular injection into a large muscle mass (e.g., gluteus). The injection site was rotated to minimize injection site reactions.
What should I do if I experience an allergic reaction after an abarelix injection?
Seek immediate medical attention. Anaphylaxis can be life-threatening. Healthcare providers are trained to manage such reactions during the observation period.

References

  1. 1
    Abarelix depot versus leuprolide plus daily antiandrogen for prostate cancer: a Phase 3 randomized trial(2004)PubMed ↗
  2. 2
    Abarelix, a GnRH antagonist, for the treatment of prostate cancer: pharmacology and clinical efficacy(2004)PubMed ↗
  3. 3
    Immediate-onset systemic allergic reactions with abarelix: post-marketing safety analysis(2005)PubMed ↗

Last updated: 2026-02-19